Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

NCT00534118 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: donor lymphocytes

Sponsor

Roswell Park Cancer Institute